The federal government on Tuesday, August 25, declared that Chloroquine is potent for the prevention of the Coronavirus infection.
Speaking with journalists, director-general of the National Agency for Food and Drug Administration and Control (NAFDAC), Christianah Mojisola Adeyeye, made this known.
She, however, added that the drug is only capable of tackling the virus at the early based on the research carried out by NAFDAC.
Adeyeye said in March 2020, the agency discovered that chloroquine is effective in fighting Covid-19 as it was used to treat over 100 patients in about 10 hospitals in China.
She further added that the drug has been used to treat many patients of Covid-19 in African countries including Ghana and Senegal.
“We realise that chloroquine can be used in the early stage of the COVID-19 infection as prophylactic treatment. Science does not lie.
“In March 2020, I was going through a literature and I found (out) that chloroquine and remdesivir killed COVID-19 in vitro – that is in the laboratory.
“We are now understanding that it is not one drug that can be effective for COVID-19. It depends on the phase of the disease. We started working with Lagos State on clinical trial for chloroquine. We are getting to know that that it is working,” Adeyeye said.